BlackRock Inc. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$26,838,375
-7.2%
8,828,413
+0.4%
0.00%0.0%
Q2 2023$28,928,056
+1.7%
8,792,722
-1.7%
0.00%0.0%
Q1 2023$28,448,206
-44.2%
8,945,977
+21.4%
0.00%
-50.0%
Q4 2022$50,991,140
+16.8%
7,368,662
+6.8%
0.00%
+100.0%
Q3 2022$43,671,000
+81.5%
6,898,975
+18.7%
0.00%0.0%
Q2 2022$24,066,000
-15.0%
5,813,340
-0.4%
0.00%0.0%
Q1 2022$28,309,000
-52.1%
5,837,111
-1.3%
0.00%
-50.0%
Q4 2021$59,058,000
-46.4%
5,912,002
+2.5%
0.00%
-33.3%
Q3 2021$110,259,000
-41.7%
5,769,709
-2.4%
0.00%
-40.0%
Q2 2021$188,972,000
+57.2%
5,909,097
+48.2%
0.01%
+25.0%
Q1 2021$120,225,000
-28.0%
3,987,526
+3.3%
0.00%
-20.0%
Q4 2020$167,093,000
-17.0%
3,861,648
+3.5%
0.01%
-28.6%
Q3 2020$201,362,000
-17.4%
3,732,394
-6.5%
0.01%
-30.0%
Q2 2020$243,736,000
+84.0%
3,993,061
+38.5%
0.01%
+66.7%
Q1 2020$132,472,000
-48.4%
2,882,313
-1.5%
0.01%
-40.0%
Q4 2019$256,697,000
-4.6%
2,925,336
-0.2%
0.01%
-9.1%
Q3 2019$269,136,000
-27.1%
2,931,105
+1.0%
0.01%
-31.2%
Q2 2019$369,197,000
-21.3%
2,902,499
-2.6%
0.02%
-23.8%
Q1 2019$468,940,000
+58.3%
2,980,606
-0.2%
0.02%
+40.0%
Q4 2018$296,223,000
-31.3%
2,986,142
+1.2%
0.02%
-21.1%
Q3 2018$431,005,000
+0.4%
2,952,089
+7.9%
0.02%
-5.0%
Q2 2018$429,286,000
-35.0%
2,735,175
-29.3%
0.02%
-37.5%
Q1 2018$660,489,000
-3.2%
3,868,157
+1.0%
0.03%0.0%
Q4 2017$682,366,000
+38.0%
3,831,371
+6.4%
0.03%
+28.0%
Q3 2017$494,415,000
+41.7%
3,599,674
+8.4%
0.02%
+38.9%
Q2 2017$348,801,000
+20.6%
3,320,329
+4.3%
0.02%
+12.5%
Q1 2017$289,259,000
+66243.8%
3,182,188
+44948.0%
0.02%
+1500.0%
Q4 2016$436,000
-73.4%
7,064
-70.7%
0.00%
-50.0%
Q3 2016$1,637,000
+429.8%
24,148
+238.1%
0.00%
Q2 2016$309,000
+59.3%
7,143
+56.3%
0.00%
Q1 2016$194,000
+189.6%
4,569
+341.0%
0.00%
Q4 2015$67,000
-18.3%
1,036
+7.9%
0.00%
Q3 2015$82,000
-45.3%
960
+8.0%
0.00%
Q2 2015$150,000
+94.8%
889
+39.6%
0.00%
Q1 2015$77,000
+8.5%
637
-17.6%
0.00%
Q4 2014$71,000
-93.2%
773
-97.3%
0.00%
-100.0%
Q3 2014$1,041,000
+6023.5%
29,024
+6321.2%
0.00%
Q2 2014$17,000
+240.0%
452
+110.2%
0.00%
Q1 2014$5,000
-99.4%
215
-99.4%
0.00%
-100.0%
Q4 2013$779,000
+19375.0%
37,148
+25000.0%
0.00%
Q3 2013$4,0001480.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders